These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 22270043)

  • 21. Delineating role of ubiquitination on nuclear factor-kappa B pathway by a computational modeling approach.
    Lee J; Choi K; Choi C
    Biochem Biophys Res Commun; 2010 Jan; 391(1):33-7. PubMed ID: 19895789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ubiquitin proteasome system as a potential target for the treatment of neurodegenerative diseases.
    Ying Z; Wang H; Wang G
    Curr Pharm Des; 2013; 19(18):3305-14. PubMed ID: 23151138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. K63-linked ubiquitination and neurodegeneration.
    Lim KL; Lim GG
    Neurobiol Dis; 2011 Jul; 43(1):9-16. PubMed ID: 20696248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ubiquitin proteasome system in synaptic and axonal degeneration: a new twist to an old cycle.
    Korhonen L; Lindholm D
    J Cell Biol; 2004 Apr; 165(1):27-30. PubMed ID: 15067020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ubiquitin-proteasome system: focus on the heart.
    Zolk O; Schenke C; Sarikas A
    Cardiovasc Res; 2006 Jun; 70(3):410-21. PubMed ID: 16497285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global changes to the ubiquitin system in Huntington's disease.
    Bennett EJ; Shaler TA; Woodman B; Ryu KY; Zaitseva TS; Becker CH; Bates GP; Schulman H; Kopito RR
    Nature; 2007 Aug; 448(7154):704-8. PubMed ID: 17687326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurodegenerative diseases regulated by ubiquitin-proteasome system].
    Hatakeyama S
    Rinsho Shinkeigaku; 2006 Nov; 46(11):890-2. PubMed ID: 17432211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ubiquitin biology in neurodegenerative disorders: From impairment to therapeutic strategies.
    Kumar D; Ambasta RK; Kumar P
    Ageing Res Rev; 2020 Aug; 61():101078. PubMed ID: 32407951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting.
    Ciechanover A
    Neurodegener Dis; 2012; 10(1-4):7-22. PubMed ID: 22327508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative UPS drug targets upstream the 26S proteasome.
    Hjerpe R; Rodríguez MS
    Int J Biochem Cell Biol; 2008; 40(6-7):1126-40. PubMed ID: 18203645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing the ubiquitin-proteasome hypothesis of neurodegeneration in vivo.
    Hernández F; Díaz-Hernández M; Avila J; Lucas JJ
    Trends Neurosci; 2004 Feb; 27(2):66-9. PubMed ID: 15106649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection.
    Nedelsky NB; Todd PK; Taylor JP
    Biochim Biophys Acta; 2008 Dec; 1782(12):691-9. PubMed ID: 18930136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS.
    Pandey UB; Nie Z; Batlevi Y; McCray BA; Ritson GP; Nedelsky NB; Schwartz SL; DiProspero NA; Knight MA; Schuldiner O; Padmanabhan R; Hild M; Berry DL; Garza D; Hubbert CC; Yao TP; Baehrecke EH; Taylor JP
    Nature; 2007 Jun; 447(7146):859-63. PubMed ID: 17568747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ubiquitin-proteasome system in neurodegeneration.
    McKinnon C; Tabrizi SJ
    Antioxid Redox Signal; 2014 Dec; 21(17):2302-21. PubMed ID: 24437518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease.
    Hong L; Huang HC; Jiang ZF
    Neurol Res; 2014 Mar; 36(3):276-82. PubMed ID: 24512022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Into the heart: the emerging role of the ubiquitin-proteasome system.
    Willis MS; Patterson C
    J Mol Cell Cardiol; 2006 Oct; 41(4):567-79. PubMed ID: 16949602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein quality control in neurodegenerative disease.
    Gestwicki JE; Garza D
    Prog Mol Biol Transl Sci; 2012; 107():327-53. PubMed ID: 22482455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting.
    Ciechanover A
    Medicina (B Aires); 2010; 70(2):105-19. PubMed ID: 20447892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants.
    Sarikas A; Carrier L; Schenke C; Doll D; Flavigny J; Lindenberg KS; Eschenhagen T; Zolk O
    Cardiovasc Res; 2005 Apr; 66(1):33-44. PubMed ID: 15769446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.